Bardet Beidle Syndrome in a Syrian Adolescent : a Rare Case Report
NCT06615011 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-09-27
Summary
Bardet-Biedl Syndrome (BBS) is an uncommon genetic disorder that affects multiple organs. and presents with a variety of characteristics. It is caused by a dysfunction in the cilia. We present a case of bradet-biedl syndrome presenting with intellectual disabilities, post-axial polydactyly, gingival hyperplasia, and a significant family history of scleroderma. The diagnosis was determined based on clinical physical examination findings. The patient is undergoing treatment with Thyroxine. Although medical staff are incapable of treatment, systems support adjust the overall well-being and quality of life for individuals with Bardet-Biedl syndrome and their families.
Conditions
- Bardet Biedl Syndrome (BBS)
Sponsors & Collaborators
-
Al Baath University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-12
- Primary Completion
- 2025-09-12
- Completion
- 2025-10-12
More Related Trials
-
Artificial Intelligence Patient App for RDEB SCCs
NCT05843994 ·Status: ACTIVE_NOT_RECRUITING
-
Investigation of Biomarkers in Susac Syndrome
NCT01273792 ·Status: UNKNOWN
-
Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)
NCT04959188 ·Status: COMPLETED
-
Oral Manifestations of Systemic Sclerosis
NCT02371005 ·Status: TERMINATED ·Phase: NA
-
Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa
NCT04285294 ·Status: UNKNOWN
-
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
NCT06177353 ·Status: RECRUITING
-
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
NCT06563414 ·Status: RECRUITING
-
Fibroblasts and Thoracic Aortic Aneurysms: in Vitro Characterization in With Marfan Syndrome and Genetic Aortic Diseases
NCT06786754 ·Status: ENROLLING_BY_INVITATION
-
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
NCT00001813 ·Status: COMPLETED
-
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT03392909 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Familial Systemic Scleroderma
NCT07343115 ·Status: RECRUITING
-
Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
NCT00533572 ·Status: TERMINATED
-
Development and Prevention of Severe Heart Disease in Systemic Sclerosis
NCT01829126 ·Status: UNKNOWN
-
Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome
NCT06742073 ·Status: RECRUITING
-
Mouth Handicap in Systemic Sclerosis
NCT04273386 ·Status: COMPLETED ·Phase: NA
-
Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis
NCT00318175 ·Status: COMPLETED ·Phase: PHASE2
-
The Possible Association Between Pseudoexfoliation Syndrome And Corneal Endothelial Cell Changes
NCT05156138 ·Status: UNKNOWN
-
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
NCT00442611 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
NCT06330350 ·Status: RECRUITING
-
Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
NCT02165111 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarker for Hurler Disease (BioHurler)
NCT02298712 ·Status: WITHDRAWN
-
Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)
NCT04757727 ·Status: COMPLETED
-
Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers
NCT01971957 ·Status: COMPLETED
-
Vitiligo, New Treatment and Serum s100B
NCT06768840 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
NCT05979831 ·Status: TERMINATED ·Phase: PHASE1/PHASE2